BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Avian flu virus
,
Rosiglitazone
,
rs2300478
,
PPARA
,
T cell differentiation
,
Influenza
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
plk1 protein
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Head and neck squamous cell carcinoma cell lines resistant or sensitive to rigosertib
Lung cancer A549 cells (KRAS mutant) after BI-2536 and fasudil combination treatment
Erythroid cells with shRNA-mediated SF3B1 knockdown
Acute myeloid leukemia cells treated with cell-specific IC50 concentrations of etoposide
Explore Curated Studies Results
Literature
Most Relevant Literature
PLK1 and FoxM1 expressions positively correlate in papillary thyroid carcinoma and their combined in…
PLK1 and its substrate MISP facilitate intrahepatic cholangiocarcinoma progression by promoting lymp…
Chronic chromosome instability induced by Plk1 results in immune suppression in breast cancer.
Discovery and optimization of dihydropteridone derivatives as novel PLK1 and BRD4 dual inhibitor for…
Control of cell proliferation by memories of mitosis.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study of Volasertib and Belinostat in Patients With Relapsed and Refractory Aggressive B-cell and T-…
Onvansertib in Combination With FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colo…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ